Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar plus Dacarbazine in Advanced Melanoma
NCT00813449Phase 2Unknown
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Aug 2008
- Primary completion
- Aug 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in melanoma, sponsored by Simcere Pharmaceutical Group. Status: unknown.
02
Drugs
endostar
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00813449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813449.